Galafold OverviewMigalastat (or 1-deoxygalactonojirimycin; trade names Galafold and formerly Amigal) is a drug for the treatment of Fabry disease, a rare genetic disorder. It was developed by Amicus Therapeutics. The US Food and Drug Administration (FDA) assigned it orphan drug status in 2004, and the European Committee for Medicinal Products for Human Use (CHMP) followed in 2006. The European Commission approved the drug in May 2016. Contents 1 Medical uses 2 Adverse...
Read more Galafold Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Migalastat
Recent Galafold Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 123mg, 150mg
NDC Database Records for Galafold: (1 result)Sorted by National Drug Code
- 71904-100 Galafold 123 mg Oral Capsule by Amicus Therapeutics U.S., Inc.